In the last trading session, 1.79 million shares of the Taysha Gene Therapies Inc (NASDAQ:TSHA) were traded, and its beta was 0.36. Most recently the company’s share price was $2.27, and it changed around -$0.14 or -5.81% from the last close, which brings the market valuation of the company to $424.54M. TSHA currently trades at a discount to its 52-week high of $3.89, offering almost -71.37% off that amount. The share price’s 52-week low was $0.50, which indicates that the current value has risen by an impressive 77.97% since then. We note from Taysha Gene Therapies Inc’s average daily trading volume that its 3-month average coming to 2.77 million.

Taysha Gene Therapies Inc (NASDAQ:TSHA) trade information

Instantly TSHA has showed a red trend with a performance of -5.81% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 28.25% year-to-date, but still down -22.79% over the last five days. On the other hand, Taysha Gene Therapies Inc (NASDAQ:TSHA) is -23.31% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $23.38, which translates to bulls needing to increase their stock price by 90.29% from its current value. Analyst projections state that TSHA is forecast to be at a low of $1.5 and a high of $44.

Taysha Gene Therapies Inc (TSHA) estimates and forecasts

Taysha Gene Therapies Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 6.07 percent over the past six months and at a 59.38% annual growth rate that is well above the industry average of 21.80%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -137.69%.

TSHA Dividends

Taysha Gene Therapies Inc’s next quarterly earnings report is expected to be released in May.